newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference

  • Minerva Neurosciences, Inc. announced that Executive Chairman & CEO Remy Luthringer, PhD, will participate in the 2026 Jefferies Global Healthcare Conference.
  • The conference will be held in New York, NY, from June 2-4, 2026.
  • Luthringer is scheduled for a fireside chat on Thursday, June 4, at 4:20 PM ET.
  • A webcast link for the presentation is available via the provided link.
  • Interested parties may contact their Jefferies representative to arrange meetings with the Minerva team.
  • A replay of the presentation will be accessible on the company's Investors & Media Events webpage for 90 days post-event.
  • Minerva Neurosciences is a clinical-stage biopharmaceutical company developing therapies for CNS disorders, including roluperidone for negative symptoms of schizophrenia.
  • Frederick Ahlholm serves as Chief Financial Officer.
  • Corey Davis, Ph.D., of LifeSci Advisors, LLC, is the media contact.